Angel Cedazo-mínguez MSc, PhD

Angel Cedazo-Minguez is the Head of Neurodegeneration cluster in the Neuroscience Therapeutic Area at Sanofi, based in Chilly-Mazarin, Paris, France. Prior to joining Sanofi in 2017, Angel was Professor in Molecular Neurogeriatrics at Karolinska Institutet (KI) (Sweden). He was also Vice-head of the Department of Neurobiology, Care Sciences and Society and co-director of the Center for Alzheimer’s Research at KI, a translational center formed by more than 80 scientists investigating pathology, diagnostic markers and targets for Alzheimer’s disease (AD).

Angel received his Ph.D. in Medicine from KI in 2002 and was named Associate Professor in 2010. From 2013 to 2017, he was appointed co-director of the Swedish Brain Power (SBP), a national network of centers of excellence to combat neurodegenerative disorders. SBP brings together the most prominent Swedish researchers in this field, joining forces in an attempt to propel the early diagnostics, treatment and care for patients with AD, Parkinson´s Disease or ALS. Angel currently holds his association to KI as professor in leave of absence. Angel’s work has been focused on investigating the pathological mechanisms by which known risk factors contribute to AD and PD, with projects towards understanding fundamental alterations in antioxidant systems, mitochondrial deficits and the metabolism of cholesterol and glucose in the brain.